Corcept Therapeutics' Share Price Falls 45% Despite 71% Gain Over Three Years.

Corcept Therapeutics (NASDAQ:CORT) has seen its share price fall 45% in the last three months, despite a 71% increase in the last three years. The company's earnings per share have dropped 2.7% annually, but revenue growth has been 24%. The decline in earnings may be a concern, but investors may be optimistic about the company's future prospects.